Summary

Global Female Pelvic Implants Market is valued at approximately USD 245 million in 2021 and is anticipated to grow with a healthy growth rate of more than 2.8% over the forecast period 2022-2029. The female pelvic implants market refers to the medical devices and products used for the treatment of various pelvic floor disorders in women. Pelvic floor disorders are a common health concern among women, particularly those who have undergone childbirth or have reached menopause. These disorders can lead to a range of symptoms such as urinary incontinence, pelvic organ prolapse, and fecal incontinence, which can significantly impact a woman's quality of life. The market demand is primarily driven by the factors such as the increasing prevalence of pelvic floor disorders, growing awareness about pelvic implants among women and the rising number of pregnancies across the world.

In addition, the increasing cases of pelvic disorders in women and the rising number of unwanted pregnancies are acting as major driving factors for market growth. According to the National Association for Incontinence, 25 million Americans struggle with urine incontinence, with 75% of them being women. The most common kind is stress urinary incontinence (SUI). Similarly, according to the Association for Pelvic Organ Prolapse Support, around 34 million women worldwide suffer from pelvic organ prolapse (POP). These increasing cases of pelvic disorders and diseases in women and growing initiatives by governments across the world for providing a healthy lifestyle for women are expected to escalate the demand for female pelvic implants in the global market. Furthermore, the increasing investments towards the development of more effective and minimally invasive implant devices and rising investments in the women’s healthcare sector are presenting lucrative opportunities for market growth over the forthcoming years. However, safety concerns regarding the implant process are restricting the market growth over the forecast period of 2022-2029.

The key regions considered for the Global Female Pelvic Implants Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue due to the presence of advanced healthcare infrastructure high adoption rate of female pelvic medications and devices. Whereas, Asia Pacific is also expected to grow at the highest growth rate over the forecasting period. Factors such as rising government initiatives towards a healthy lifestyle for women, an increasing number of pelvic floor disorders and a growing number of pregnancies are burgeoning the market growth in the forecasting years.

Major market players included in this report are:
Johnson & Johnson Services, Inc.
Coloplast Group
Becton, Dickinson and Company
Boston Scientific Corporation
pfm medical ag
American Medical Systems, LLC
Cook Medical
Betatech Medical
Dipromed Srl
Promedon S.A.

Recent Developments in the Market:
 In September 2021, Colopast announced the opening of a new production facility in Costa Rica to assist in the global growth of the company and to increase the production of medical devices including ostomy pouches and catheters for people who require intimate healthcare. The new production facility will also help to meet the growing demand by producing and supplying medical products that will enhance the quality of life for people worldwide.
 In November 2020, Colopast, a multinational company that manufactures, develops and markets medical devices announced the acquisition of Nine Continents Medical, Inc. The company has developed an implanted tibial nerve stimulation therapy for overactive bladder. The purchase price is made up of a USD 145 million upfront cash payment plus a dependent future milestone payment.


Global Female Pelvic Implants Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Indication, End-user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Vaginal Mesh Implants
Vaginal Sling
Vaginal Graft Implants

By Indication:
Pelvic Organ Prolapse
Stress Urinary Incontinence

By End-user:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Female Pelvic Implants Market, by Region, 2019-2029 (USD Million)
1.2.2. Female Pelvic Implants Market, by Product Type, 2019-2029 (USD Million)
1.2.3. Female Pelvic Implants Market, by Indication, 2019-2029 (USD Million)
1.2.4. Female Pelvic Implants Market, by End-user, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Female Pelvic Implants Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Female Pelvic Implants Market Dynamics
3.1. Female Pelvic Implants Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of pelvic floor disorders
3.1.1.2. Growing awareness about pelvic implants among women
3.1.1.3. Rising number of pregnancies across the world
3.1.2. Market Challenges
3.1.2.1. Safety concerns regarding the implant process
3.1.3. Market Opportunities
3.1.3.1. Increasing development of more effective and minimally invasive implant devices
3.1.3.2. Rising investments in the women’s healthcare sector
Chapter 4. Global Female Pelvic Implants Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Female Pelvic Implants Market, by Product Type
6.1. Market Snapshot
6.2. Global Female Pelvic Implants Market by Product Type, Performance - Potential Analysis
6.3. Global Female Pelvic Implants Market Estimates & Forecasts by Product Type 2019-2029 (USD Million)
6.4. Female Pelvic Implants Market, Sub Segment Analysis
6.4.1. Vaginal Mesh Implants
6.4.2. Vaginal Sling
6.4.3. Vaginal Graft Implants
Chapter 7. Global Female Pelvic Implants Market, by Indication
7.1. Market Snapshot
7.2. Global Female Pelvic Implants Market by Indication, Performance - Potential Analysis
7.3. Global Female Pelvic Implants Market Estimates & Forecasts by Indication 2019-2029 (USD Million)
7.4. Female Pelvic Implants Market, Sub Segment Analysis
7.4.1. Pelvic Organ Prolapse
7.4.2. Stress Urinary Incontinence
Chapter 8. Global Female Pelvic Implants Market, by End-user
8.1. Market Snapshot
8.2. Global Female Pelvic Implants Market by End-user, Performance - Potential Analysis
8.3. Global Female Pelvic Implants Market Estimates & Forecasts by End-user 2019-2029 (USD Million)
8.4. Female Pelvic Implants Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Ambulatory Surgical Centres
8.4.3. Specialty Clinics
Chapter 9. Global Female Pelvic Implants Market, Regional Analysis
9.1. Female Pelvic Implants Market, Regional Market Snapshot
9.2. North America Female Pelvic Implants Market
9.2.1. U.S. Female Pelvic Implants Market
9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Female Pelvic Implants Market
9.3. Europe Female Pelvic Implants Market Snapshot
9.3.1. U.K. Female Pelvic Implants Market
9.3.2. Germany Female Pelvic Implants Market
9.3.3. France Female Pelvic Implants Market
9.3.4. Spain Female Pelvic Implants Market
9.3.5. Italy Female Pelvic Implants Market
9.3.6. Rest of Europe Female Pelvic Implants Market
9.4. Asia-Pacific Female Pelvic Implants Market Snapshot
9.4.1. China Female Pelvic Implants Market
9.4.2. India Female Pelvic Implants Market
9.4.3. Japan Female Pelvic Implants Market
9.4.4. Australia Female Pelvic Implants Market
9.4.5. South Korea Female Pelvic Implants Market
9.4.6. Rest of Asia Pacific Female Pelvic Implants Market
9.5. Latin America Female Pelvic Implants Market Snapshot
9.5.1. Brazil Female Pelvic Implants Market
9.5.2. Mexico Female Pelvic Implants Market
9.5.3. Rest of Latin America Female Pelvic Implants Market
9.6. Rest of The World Female Pelvic Implants Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Johnson & Johnson Services, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Coloplast Group
10.2.3. Becton, Dickinson and Company
10.2.4. Boston Scientific Corporation
10.2.5. pfm medical ag
10.2.6. American Medical Systems, LLC
10.2.7. Cook Medical
10.2.8. Betatech Medical
10.2.9. Dipromed Srl
10.2.10. Promedon S.A.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption